scholarly journals Efficacy of Intravenous Tranexamic Acid in reducing Blood Loss in Elective Cesarean Delivery

2019 ◽  
Vol 2 (1) ◽  
pp. 62-67
Author(s):  
Sebak Shrestha ◽  
Josie Baral ◽  
Geeta Gurung

N/A

2017 ◽  
Vol 11 (2) ◽  
pp. 37-41 ◽  
Author(s):  
Sarita Sitaula ◽  
DK Uprety ◽  
A Thakur ◽  
T Pradhan

Aims:The aim of this study was to evaluate the effect of preoperative administration of rectal misoprostol onblood loss during and after elective cesarean delivery.Methods:It was a randomized trial including 200 women, divided into two groups (group A and group B), who were planned for elective cesarean delivery and didn’t have risk of postpartum hemorrhage (PPH). Group A received 400μg misoprostol per-rectal preoperatively and intravenous infusion of oxytocin after delivery as hospital protocol.Group B received only intravenous infusion of oxytocin. Primary outcome measureswere the estimated amount of intraoperative and postoperative (24 hours) blood loss and changes in hemoglobin levels 48 hours after delivery.Results:Intraoperative and postoperative blood loss in rectal misoprostol and oxytocin group were significantly reducedin comparison to oxytocin only group. Mean blood loss in groupA was 326.9±116.2 mlwhereas; in group B was 397.7±110.1 ml with p value of < 0.001 which was significant.The difference between preoperative and postoperative hemoglobin level after 48 hours was also significant (1.10±0.51 vs 1.35± 0.49 g/dl with p value <0.001).Conclusion: Preoperative rectal misoprostol was found to be an effective measure to reduce the intraoperative and postoperative blood loss during elective cesarean delivery.


2015 ◽  
Vol 131 (3) ◽  
pp. 265-268 ◽  
Author(s):  
Ahmed M. Maged ◽  
Omneya M. Helal ◽  
Moutaz M. Elsherbini ◽  
Marwa M. Eid ◽  
Rasha O. Elkomy ◽  
...  

2015 ◽  
Vol 123 (1) ◽  
pp. 92-100 ◽  
Author(s):  
Vesela P. Kovacheva ◽  
Mieke A. Soens ◽  
Lawrence C. Tsen

Abstract Background: The administration of uterotonic agents during cesarean delivery is highly variable. The authors hypothesized a “rule of threes” algorithm, featuring oxytocin 3 IU, timed uterine tone evaluations, and a systematic approach to alternative uterotonic agents, would reduce the oxytocin dose required to obtain adequate uterine tone. Methods: Sixty women undergoing elective cesarean delivery were randomized to receive a low-dose bolus or continuous infusion of oxytocin. To blind participants, the rule group simultaneously received intravenous oxytocin (3 IU/3 ml) and a “wide-open” infusion of 0.9% normal saline (500 ml); the standard care group received intravenous 0.9% normal saline (3 ml) and a “wide-open” infusion of oxytocin (30 IU in 0.9% normal saline/500 ml). Uterine tone was assessed at 3, 6, 9, and 12 min, and if inadequate, additional uterotonic agents were administered. Uterine tone, total dose and timing of uterotonic agent use, maternal hemodynamics, side effects, and blood loss were recorded. Results: Adequate uterine tone was achieved with lower oxytocin doses in the rule versus standard care group (mean, 4.0 vs. 8.4 IU; point estimate of the difference, 4.4 ± 1.0 IU; 95% CI, 2.60 to 6.15; P &lt; 0.0001). No additional oxytocin or alternative uterotonic agents were needed in either group after 6 min. No differences in the uterine tone, maternal hemodynamics, side effects, or blood loss were observed. Conclusion: A “rule of threes” algorithm using oxytocin 3 IU results in lower oxytocin doses when compared with continuous-infusion oxytocin in women undergoing elective cesarean delivery.


2011 ◽  
Vol 112 (5) ◽  
pp. 1041-1047 ◽  
Author(s):  
Alexander Butwick ◽  
Vicki Ting ◽  
Lindsey Atkinson Ralls ◽  
Scott Harter ◽  
Edward Riley

2011 ◽  
Vol 55 (6) ◽  
pp. 283-284
Author(s):  
Alexander Butwick, ◽  
Vicki Ting, ◽  
Lindsey Atkinson Ralls, ◽  
Scott Harter, ◽  
Edward Riley

Sign in / Sign up

Export Citation Format

Share Document